Clinical Trial Update: Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on early prediction of therapeutic response to targeted therapy in stage IIIB/IV or recurrent non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Utah | Conditions: Cancer, Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED